Last Updated on June 22, 2023

Tumori- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Wichtig Publishing Srl

Abbreviation: Tumori




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

1.67

SJR

 0.443

h-Index

 56

Rank

 11505

Important Details

Title Tumori
Standard Abbreviation Tumori
Type of Publication Journal
Discipline Medicine (miscellaneous) (Q3); Oncology (Q3); Cancer Research (Q4)
Impact Score 1.67
SCImago Journal Rank (SJR) 0.443
h-index 56
Overall Rank 11505
Publisher Name Wichtig Publishing Srl
Publication Country Italy
International Standard Serial Number (ISSN) 03008916, 20382529
Coverage and History 1946-2022
Best Quartile Q3
Total Citations Received
(Last 3 Year)
496

About Tumori


Tumori is a journal published by Wichtig Publishing Srl. This journal covers the area[s] related to Medicine (miscellaneous), Oncology, Cancer Research, etc. The coverage history of this journal is as follows: 1946-2022. The rank of this journal is 11505. This journal's impact score, h-index, and SJR are 1.67, 56, and 0.443, respectively. The ISSN of this journal is/are as follows: 03008916, 20382529.

The best quartile of Tumori is Q3. This journal has received a total of 496 citations during the last three years (Preceding 2022).


Tumori Impact Score 2022-2023


The latest impact score (IS) of the Tumori is 1.67. It is computed in the year 2023 as per its definition and based on Scopus data. 1.67

It is increased by a factor of around 0.17, and the percentage change is 11.33% compared to the preceding year 2021, indicating a rising trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Tumori Impact Score 2023


Impact Score 2022 of Tumori is 1.67. If a similar upward trend continues, IS may increase in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of Tumori. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 1.67
2021 1.50
2020 1.27
2019 1.29
2018 0.85
2017 1.05
2016 0.91
2015 0.89
2014 1.08

Tumori h-index


  Table Setting

The h-index of Tumori is 56. By definition of the h-index, this journal has at least 56 published articles with more than 56 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Tumori ISSN


The International Standard Serial Number (ISSN) of Tumori is/are as follows: 03008916, 20382529.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Tumori Ranking and SCImago Journal Rank (SJR)


The Tumori is ranked 11505 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.443.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Tumori Publisher


Table Setting

The publisher of Tumori is Wichtig Publishing Srl. The publishing house of this journal is located in the Italy. Its coverage history is as follows: 1946-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Tumori is Tumori. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Tumori') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Tumori


If your area of research or discipline is related to Medicine (miscellaneous), Oncology, Cancer Research, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Tumori?

The latest impact score of Tumori is 1.67. It is computed in the year 2023.


What is the h-index of Tumori?

The latest h-index of Tumori is 56. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Tumori?

The latest SCImago Journal Rank (SJR) of Tumori is 0.443. It is calculated in the year 2023.


What is the ranking of Tumori?

The latest ranking of Tumori is 11505. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Tumori?

Tumori is published by Wichtig Publishing Srl. The publication country of this journal is Italy.


What is the abbreviation of Tumori?

This standard abbreviation of Tumori is Tumori.


Is "Tumori" a Journal, Conference or Book Series?

Tumori is a journal published by Wichtig Publishing Srl.


What is the scope of Tumori?

The scope of Tumori is as follows:

  • Medicine (miscellaneous)
  • Oncology
  • Cancer Research

For detailed scope of Tumori, check the official website of this journal.


What is the ISSN of Tumori?

The International Standard Serial Number (ISSN) of Tumori is/are as follows: 03008916, 20382529.


What is the best quartile for Tumori?

The best quartile for Tumori is Q3.


What is the coverage history of Tumori?

The coverage history of Tumori is as follows 1946-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Current Sociology Journal SAGE Publications Ltd 6591 76 2.29
Journal of Business Finance and Accounting Journal Wiley-Blackwell Publishing Ltd 3221 84 3.68
Entrepreneurship Theory and Practice Journal Wiley-Blackwell 338 185 12.75
Sex Education Journal Routledge 5168 41 2.82
Natural Solutions Trade Journal Innovision Health Media 28581 1 0.00
Exploration Geophysics Journal Taylor and Francis Ltd. 16383 48 1.17
Genes and Nutrition Journal BioMed Central Ltd. 6154 61 3.28
Proceedings of the Royal Society of Queensland Journal Royal Society of Queensland 22998 12 0.48
Journal of Medical Toxicology Journal Springer New York 8639 55 2.01
Cuadernos de historia (Santiago, Chile) Journal Universidad de Chile 20081 4 0.25

Check complete list




Tumori Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 1.67
2021 1.50
2020 1.27
2019 1.29
2018 0.85
2017 1.05
2016 0.91
2015 0.89
2014 1.08



Top Journals/Conferences in Medicine (miscellaneous)

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Publishing Group | United Kingdom

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Lancet, The
Elsevier Ltd. | United Kingdom

Physiological Reviews
American Physiological Society | United States

MMWR supplements
Epidemiology Program Office | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

Nature Reviews Disease Primers
Nature Publishing Group | United Kingdom

Current Protocols in Bioinformatics
John Wiley & Sons Inc. | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Annual Review of Public Health
Annual Reviews Inc. | United States

Nature Reviews Methods Primers
Springer Nature | United States

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Cancer Discovery
American Association for Cancer Research Inc. | United States

Lancet Regional Health - Europe, The
Elsevier Ltd. | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of Thoracic Oncology
International Association for the Study of Lung Cancer | United States

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

See All

Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Cell Host and Microbe
Cell Press | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

Clinical Cancer Research
American Association for Cancer Research Inc. | United States

Annual Review of Cancer Biology
Annual Reviews Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United States

Trends in Cancer
Cell Press | United States

See All